Neoadjuvant chemotherapy (NAC) for breast cancer (BC) is the gold standard treatment for locally advanced tumors (LABC) that aims at achieving a complete pathological response (pCR). Studies have been conducted to evaluate and identify te concordance between radiological, histopathological and biological variables of BC and final response to therapy, verified by definitive histological examination after surgery.

Buonomo, O.c., Grasso, A., Pistolese, C.a., Anemona, L., Portarena, I., Meucci, R., et al. (2020). Evaluation of Concordance Between Histopathological, Radiological and Biomolecular Variables in Breast Cancer Neoadjuvant Treatment. ANTICANCER RESEARCH, 40(1), 281-286 [10.21873/anticanres.13950].

Evaluation of Concordance Between Histopathological, Radiological and Biomolecular Variables in Breast Cancer Neoadjuvant Treatment

Buonomo, Oreste Claudio;Pistolese, Chiara Adriana;Anemona, Lucia;Vanni, Gianluca
2020-01-01

Abstract

Neoadjuvant chemotherapy (NAC) for breast cancer (BC) is the gold standard treatment for locally advanced tumors (LABC) that aims at achieving a complete pathological response (pCR). Studies have been conducted to evaluate and identify te concordance between radiological, histopathological and biological variables of BC and final response to therapy, verified by definitive histological examination after surgery.
2020
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/36 - DIAGNOSTICA PER IMMAGINI E RADIOTERAPIA
English
Con Impact Factor ISI
Breast cancer; MRI accuracy; complete pathological response; histological examination; neoadjuvant chemotherapy; Breast Neoplasms; Disease-Free Survival; Female; Humans; Immunophenotyping; Ki-67 Antigen; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Neoadjuvant Therapy
Buonomo, O.c., Grasso, A., Pistolese, C.a., Anemona, L., Portarena, I., Meucci, R., et al. (2020). Evaluation of Concordance Between Histopathological, Radiological and Biomolecular Variables in Breast Cancer Neoadjuvant Treatment. ANTICANCER RESEARCH, 40(1), 281-286 [10.21873/anticanres.13950].
Buonomo, Oc; Grasso, A; Pistolese, Ca; Anemona, L; Portarena, I; Meucci, R; Morando, L; Deiana, C; Materazzo, M; Vanni, G
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/233394
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 15
social impact